Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 25;12(8):e064086.
doi: 10.1136/bmjopen-2022-064086.

Nutritional therapy in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis

Mariana Dantas de Carvalho Vilar  1   2 , Karla Monica Dantas Coutinho  1   2 , Sancha Helena de Lima Vale  2   3 , Gidyenne Christine Bandeira Silva Medeiros  3   4 , Grasiela Piuvezam  4   5 , Lucia Leite-Lais  6   3 , Jose Brandao-Neto  1   7
Affiliations

Nutritional therapy in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis

Mariana Dantas de Carvalho Vilar et al. BMJ Open. .

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease characterised by the degeneration of motor neurons. Nutritional interventions in ALS are essential and must be based on scientific evidence to provide quality of healthcare, improve the quality of life and increase survival time. Therefore, this protocol of systematic reviews and meta-analyses aims to present a synthesis of evidence-based recommendations to support adequate nutrition therapy for patients with ALS.

Methods and analysis: The search will be performed using the following databases: PubMed, Excerpta Medica Database (Embase), Scopus, SciELO, Web of Science, LILACS, Cochrane Central Register of Controlled Trials (CENTRAL), ScienceDirect, ProQuest and Google Scholar. We will include clinical practice guidelines, treatment protocols, systematic reviews and clinical trials according to the three research questions to be answered related to nutrition therapy and interventions in patients with ALS. This protocol will be developed in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols. To evaluate the methodological quality of the studies, Appraisal of Guidelines, Research and Evaluation II, Cochrane Risk of Bias 2.0 and Risk of Bias In Non-randomized Studies of Interventions (ROBINS-I) tools will be used. In addition, the Grading of Recommendations Assessment, Development and Evaluation will be used to assess the quality of evidence and the strength of the recommendations. The findings will be summarised and presented descriptively according to the Cochrane Collaboration Handbook and the standard statistical meta-analysis techniques.

Ethics and dissemination: Ethical approval and human consent are not required because this is a protocol for systematic review and only secondary data will be used. Findings will be published in a peer-reviewed journal and presented at conferences. In case of any changes in this protocol, amendments will be updated in International Prospective Register of Systematic Reviews (PROSPERO) and the modifications will be explained in the final report of this review.

Prospero registration number: CRD42021233088.

Keywords: NUTRITION & DIETETICS; Neuromuscular disease; Protocols & guidelines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162–72. 10.1056/NEJMra1603471 - DOI - PubMed
    1. Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol 2017;30:599–607. 10.1097/WCO.0000000000000488 - DOI - PubMed
    1. Xu L, Liu T, Liu L, et al. . Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 2020;267:944–53. 10.1007/s00415-019-09652-y - DOI - PubMed
    1. GBD . Motor neuron disease Collaborators. global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2016;17:1083–97. - PMC - PubMed
    1. van Es MA, Hardiman O, Chio A, et al. . Amyotrophic lateral sclerosis. Lancet 2017;390:2084–98. 10.1016/S0140-6736(17)31287-4 - DOI - PubMed